Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)
Product Specifications
CAS Number
2249888-53-5
Synonyms
BFCR 4350A; RG 6160; RO 7187797
Additionnal Information
Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040225-500 1x 500 µL
Major Vault Protein (MVP) (1032), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472044-500 1x 500 µL
TIMP2 (Tissue Inhibitor of Metalloproteinase 2) (TIMP2/2044), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881131-500 1x 500 µL
CD45RA (PTPRC/1131), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471025-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26 + 57), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680421-500 1x 500 µL
Neurofilament (NF-H) (NF421), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details